» Articles » PMID: 28937221

In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract Under Fed and Fasted Conditions

Abstract

In vivo drug dissolution in the gastrointestinal (GI) tract is largely unmeasured. The purpose of this clinical study was to evaluate the in vivo drug dissolution and systemic absorption of the BCS class IIa drug ibuprofen under fed and fasted conditions by direct sampling of stomach and small intestinal luminal content. Expanding current knowledge of drug dissolution in vivo will help to establish physiologically relevant in vitro models predictive of drug dissolution. A multilumen GI catheter was orally inserted into the GI tract of healthy human subjects. Subjects received a single oral dose of ibuprofen (800 mg tablet) with 250 mL of water under fasting and fed conditions. The GI catheter facilitated collection of GI fluid from the stomach, duodenum, and jejunum. Ibuprofen concentration in GI fluid supernatant and plasma was determined by LC-MS/MS. A total of 23 subjects completed the study, with 11 subjects returning for an additional study visit (a total of 34 completed study visits). The subjects were primarily white (61%) and male (65%) with an average age of 30 years. The subjects had a median [min, max] weight of 79 [52, 123] kg and body mass index of 25.7 [19.4, 37.7] kg/m. Ibuprofen plasma levels were higher under fasted conditions and remained detectable for 28 h under both conditions. The AUC and C were lower in fed subjects vs fasted subjects, and T was delayed in fed subjects vs fasted subjects. Ibuprofen was detected immediately after ingestion in the stomach under fasting and fed conditions until 7 h after dosing. Higher levels of ibuprofen were detected in the small intestine soon after dosing in fasted subjects compared to fed. In contrast to plasma drug concentration, overall gastric concentrations remained higher under fed conditions due to increased gastric pH vs fasting condition. The gastric pH increased to near neutrality after feedingbefore decreasing to acidic levels after 7 h. Induction of the fed state reduced systemic levels but increased gastric levels of ibuprofen, which suggest that slow gastric emptying and transit dominate the effect for plasma drug concentration. The finding of high levels of ibuprofen in stomach and small intestine 7 h post dosing was unexpected. Future work is needed to better understand the role of various GI parameters, such as motility and gastric emptying, on systemic ibuprofen levels in order to improve in vitro predictive models.

Citing Articles

Encapsulation of a drug into electrospun fibers spun from water soluble polymers to control solubility and release.

Yi L, Shi L, Moczo J, Pukanszky B Heliyon. 2024; 10(20):e38935.

PMID: 39640617 PMC: 11620111. DOI: 10.1016/j.heliyon.2024.e38935.


Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling.

Kowthavarapu V, Charbe N, Gupta C, Iakovleva T, Stillhart C, Parrott N AAPS J. 2024; 26(3):44.

PMID: 38575716 DOI: 10.1208/s12248-024-00912-y.


Stochastic Differential Equation-based Mixed Effects Model of the Fluid Volume in the Fasted Stomach in Healthy Adult Human.

Wang K, Marciani L, Amidon G, Smith D, Sun D AAPS J. 2023; 25(5):76.

PMID: 37498389 DOI: 10.1208/s12248-023-00840-3.


Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study.

Huang C, Yin Z, Yang Y, Mo N, Yang H, Wang Y Drug Des Devel Ther. 2023; 17:1881-1888.

PMID: 37384214 PMC: 10295470. DOI: 10.2147/DDDT.S404756.


Levocetirizine-Loaded Electrospun Fibers from Water-Soluble Polymers: Encapsulation and Drug Release.

Yi L, Cui L, Cheng L, Moczo J, Pukanszky B Molecules. 2023; 28(10).

PMID: 37241927 PMC: 10223816. DOI: 10.3390/molecules28104188.


References
1.
Davies N . Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998; 34(2):101-54. DOI: 10.2165/00003088-199834020-00002. View

2.
Yu A, Baker J, Fioritto A, Wang Y, Luo R, Li S . Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract. Mol Pharm. 2016; 14(2):345-358. DOI: 10.1021/acs.molpharmaceut.6b00641. View

3.
Laska E, Sunshine A, Marrero I, Olson N, Siegel C, McCormick N . The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther. 1986; 40(1):1-7. DOI: 10.1038/clpt.1986.129. View

4.
Hens B, Corsetti M, Spiller R, Marciani L, Vanuytsel T, Tack J . Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities. Int J Pharm. 2016; 519(1-2):79-97. DOI: 10.1016/j.ijpharm.2016.11.063. View

5.
Amidon G, Lennernas H, Shah V, Crison J . A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995; 12(3):413-20. DOI: 10.1023/a:1016212804288. View